Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,190.00
Bid: 12,210.00
Ask: 12,214.00
Change: 162.00 (1.35%)
Spread: 4.00 (0.033%)
Open: 12,036.00
High: 12,214.00
Low: 12,024.00
Prev. Close: 12,028.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 4-France gives hospital staff COVID shots as it plays catch-up with neighbours

Mon, 04th Jan 2021 08:29

* France criticised for slow vaccine roll-out

* French regulator: more information needed on AstraZeneca

* https://graphics.reuters.com/world-coronavirus-tracker-and-maps/
(Recasts, adds details)

By Sudip Kar-Gupta and Richard Lough

PARIS, Jan 4 (Reuters) - France is accelerating its COVID-19
vaccination of medical staff in hospitals, its health minister
said on Monday, after an initial roll-out that was slowed by
bureaucracy and precaution in one of the most vaccine-sceptical
countries in the world.

Health Minister Olivier Veran said several thousand COVID-19
shots developed by Pfizer and Germany's BioNTech
had been administered across France on Monday.

France was slow off the mark, delivering just 516 COVID-19
inoculations during the first week of a campaign that focused on
nursing home residents.

"We have decided to accelerate the campaign by widening the
target group to health staff without waiting to complete the
vaccination campaign in retirement homes," Veran said during a
visit to a Paris hospital.

The sluggish start compared with European neighbours such as
Britain and Germany irritated President Emmanuel Macron, who has
called a meeting with his prime minister and health minister on
Monday evening to speed up deployment of the vaccine.

Macron wanted to "put pressure on the system" and quicken
the vaccine's deployment, an Elysee official said.

"It's going too slowly," epidemiologist and government
adviser Arnaud Fontanet told France Info radio.

"But the real deadline is to reach 5-10 million
(vaccinations) by the end of March, because that's the point at
which you have a real impact on the spread of the virus."

The coronavirus has killed more than 65,000 people in
France, the seventh-highest national toll globally. Even so, a
survey over the weekend showed six in every 10 French citizens
intend to refuse vaccination.

Fontanet said it would be "useful" to simplify the
bureaucracy involved in the vaccination roll-out. He stopped
short of saying whether a mandatory consultation with a doctor
several days before getting a COVID jab was time wasted.

CAUTIOUS APPROACH

A slow vaccination campaign risks jeopardising France's
recovery from an unprecedented economic slump in a time of
peace.

France's National Academy of Medicine last week said the
government was taking "excessive precautions". Government
officials have said vaccinating in care homes was complex
logistically.

A spokesman for nursing home operator Korian said that the
company had been told to be ready for vaccinations at three of
its sites in the greater Paris area on Monday but that the doses
had not yet been delivered.

Britain, which has used more than a million COVID-19 vaccine
shots already, has now begun vaccinating its population with the
shot developed by Oxford University and AstraZeneca,
boasting a scientific triumph.

Dominique Le Guludec, head of France's medical regulator,
said there was still insufficient data to approve the
AstraZeneca vaccine.

"We prefer to wait another 15 days if necessary to have all
the data we need on safety and efficacy," Le Guludec told BFM
TV.

The EU's medical watchdog is expected to decide on approval
of a third vaccine, developed by Moderna, later this
week.

France on Monday sent 12 million pupils back to school after
the Christmas holidays as planned.

Restaurants, bars, museums and cinemas remain shut. It was
unlikely restaurants would re-open as initially planned on Jan.
20, government minister Alain Griset said on Sunday.
(Reporting by Sudip Kar-Gupta and Richard Lough; Additional
reporting by Michel Rose; Editing by Nick Macfie, Hugh Lawson,
William Maclean)

More News
30 May 2024 09:23

LONDON BROKER RATINGS: Jefferies and UBS cut Anglo American

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

Read more
30 May 2024 07:40

LONDON BRIEFING: Dr Martens cuts payout as profit plummets

(Alliance News) - Stocks in London are called to open lower on Thursday, with investors nervous ahead of Friday's US inflation print.

Read more
29 May 2024 08:54

IN BRIEF: AstraZeneca drug lowers cholesterol in phase 1 trial

AstraZeneca PLC - Cambridge, England-based pharmaceuticals - Reports positive results in a phase 1 trial of cholesterol drug candidate AZD0780, an oral small molecule PCSK9 inhibitor. Administered on top of rosuvastatin treatment, AZD0780 showed a statistically significant reduction in low-density lipoprotein cholesterol in plasma for test participants with hypercholesterolaemia, Astra says, while no serious adverse events were reported. "Elevated LDL-C levels in plasma is a key risk factor for cardiovascular disease and is estimated to cause 2.6 million deaths worldwide annually," Astra notes.

Read more
28 May 2024 07:02

AstraZeneca experimental lung cancer drug shows promising results

(Sharecast News) - AstraZeneca's experimental lung cancer drug showed improved overall survival rates in phase III trials, the pharmaceutical giant said on Tuesday.

Read more
27 May 2024 07:49

IN BRIEF: Astra, Daiichi hail positive survival data for Dato-DXd

AstraZeneca PLC - Cambridge, UK-based pharmaceutical firm - Alongside Japan's Daiichi Sankyo Co Ltd, notes positive data for datopotamab deruxtecan in phase III trial on lung cancer. Says the treatment, also known as Dato-DXd, showed a clinically meaningfully improvement in overall survival versus chemotherapy in advanced nonsquamous non-small cell lung cancer. The results build upon the positive progression-free survival findings presented back in 2023, Astra adds.

Read more
22 May 2024 09:53

LONDON BROKER RATINGS: Barclays cuts NextEnergy but lifts JLEN

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more
22 May 2024 02:00

British firms expecting hard time in China market, lobby group warns

BEIJING, May 22 (Reuters) - British firms expect doing business in China to become harder over the next five years, a British business lobby group said on Wednesday, as Beijing strives to halt a retreat in foreign funds from a market once seen as the engine of global growth.

Read more
21 May 2024 19:00

Sector movers: Stocks slip amid light profit-taking

(Sharecast News) - Stocks ended a tad lower as investors waited on a raft of US central bank speakers scheduled for after the close of markets in London.

Read more
21 May 2024 17:20

Europe's STOXX 600 ends lower as rate uncertainty prevails

Focus on Fed minutes, Nvidia earnings

*

Read more
21 May 2024 17:04

LONDON MARKET CLOSE: London dips as eyes turn to UK inflation reading

(Alliance News) - Stock prices in London closed in the red on Tuesday, as investors nervously eye a key UK inflation reading, which could prompt the Bank of England to consider interest rate cuts.

Read more
21 May 2024 15:00

London close: Stocks fall ahead of key inflation reading

(Sharecast News) - London stocks ended in negative territory on Tuesday, influenced by the latest UK economic outlook from the International Monetary Fund (IMF) and comments from US Federal Reserve officials.

Read more
21 May 2024 12:03

CORRECT: Stocks fall but pound up as IMF ups UK forecast

(Correcting London Stock Exchange index prices.)

Read more
21 May 2024 12:00

LONDON MARKET MIDDAY: Stocks fall but pound up as IMF ups UK forecast

(Alliance News) - Stock prices in Europe were lower heading into Tuesday afternoon, with shares in New York also set for a muted open, as a recent rally for equities takes a pause.

Read more
21 May 2024 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030

*

Read more
21 May 2024 09:04

LONDON MARKET OPEN: FTSE 100 declines after Asian stocks fall

(Alliance News) - Stock prices in London opened in the red on Tuesday, with some US interest rate cut optimism cooling after hawkish words from Federal Reserve central bankers.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.